Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) Peptide
-
- Target See all CHRNA7 products
- CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Purpose
- Nicotinic Acetylcholine Receptor α7/CHRNA7 (extracellular) Negative Control Antigen
- Sequence
- (C)KELVKNYNPL ER, correspond ing to amino acid residues 31-42 of rat nAChRα7 (Accession Q05941).
- Characteristics
- Synthetic peptide, A Blocking peptide for Anti-Nicotinic Acetylcholine Receptor α7 (CHRNA7) (extracellular) Antibody (ABIN7043067, ABIN7044631 and ABIN7044632)) and Anti-Nicotinic Acetylcholine Receptor α7 (CHRNA7) (extracellular)-ATTO Fluor-633 Antibody (#ABIN7043068). Intended to be used as a negative control.
- Purity
- >70 %
-
-
- Application Notes
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Comment
-
Confirmed by amino acid analysis and mass spectrometry.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 100 μL double distilled water (DDW).
- Storage
- RT,-20 °C
- Storage Comment
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-